Literature DB >> 13965178

Heterotypic antibody response after feeding of monovalent attenuated live poliovaccine.

A ASHKENAZI, J L MELNICK.   

Abstract

Entities:  

Keywords:  ANTIBODY FORMATION; POLIOVIRUS VACCINE, ORAL

Mesh：

Substances：

Year:  1962        PMID： 13965178     DOI： 10.1056/NEJM196212132672404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  [STUDIES ON THE DETECTION OF NEUTRALIZING AND COMPLEMENT BINDING ANTIBODIES FOLLOWING ORAL POLIOMYELITIS VACCINATION].

Authors:  J SCHMIDT; G NAUMANN
Journal:  Klin Wochenschr       Date:  1965-05-15

2.  [HETEROLOGOUS ANTIBODY FORMATION AFTER IMMUNIZATION WITH POLIOMYELITIS VIRUSES].

Authors:  O GOETZ; B OHRT
Journal:  Klin Wochenschr       Date:  1964-12-01

3.  Poliomyelitis: epidemiology and prophylaxis. 4. Serological and virological surveys conducted after a mass vaccination campaign for the control of a threatening poliomyelitis epidemic.

Authors:  D Metselaar; K McDonald; W Gemert; B Nottay; J M Muli
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

4.  Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial.

Authors:  Fatima Mir; Farheen Quadri; Ondrej Mach; Imran Ahmed; Zaid Bhatti; Asia Khan; Najeeb Ur Rehman; Elias Durry; Maha Salama; Steven M Oberste; William C Weldon; Roland W Sutter; Anita K M Zaidi
Journal:  Lancet Infect Dis       Date:  2015-06-17       Impact factor: 25.071

Review 5.  Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.

Authors:  Edward Pk Parker; Natalie A Molodecky; Margarita Pons-Salort; Kathleen M O'Reilly; Nicholas C Grassly
Journal:  Expert Rev Vaccines       Date:  2015-07-09       Impact factor: 5.217
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.